Press Releases

 
Press Releases
  Date Title View
Sep 3, 2009
LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today that Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present at the Thomas Weisel Partners 2009 Healthcare Conference on Thursday, September 10, 2009 at 10:55 a.m. Eastern Time.  The conference will be held September 9-11, 2009 at the Four Seasons ...
Jun 2, 2009
LEXINGTON, Mass and London -- Concert Pharmaceuticals and GlaxoSmithKline (NYSE: GSK) announced today that they will collaborate to develop and commercialize deuterium-containing medicines. The deal includes three of Concert’s research and development programs; namely, CTP-518, a protease inhibitor for the treatment of HIV expected to e...
Jun 1, 2009
LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today its participation in the private company forum at the 30th Annual Goldman Sachs Global Healthcare Conference on Monday, June 8, 2009 from 3:30 – 5:30 p.m. Eastern Time.  Roger Tung, Ph.D., President and Chief Executive Officer, and Nancy Stuart, ...
May 11, 2009
LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today that its first patents have been granted by the U.S. Patent and Trademark Office.  These patents relate to specific compounds derived from Concert’s deuterium chemistry platform.  U.S. Patents 7,514,068 and 7,528,131 specifically claim deuterium analogs of ri...
Mar 16, 2009
LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today positive Phase I clinical trial results of CTP-347, an investigational non-hormonal treatment for vasomotor symptoms (hot flashes). CTP-347, a novel deuterium-modified analog of paroxetine discovered at Concert, was well-tolerated at all doses. Paroxetine is a serotonin reup...
Mar 9, 2009
LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today that Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present at the Cowen and Company 29th Annual Health Care Conference on Monday, March 16, 2009 at 11:00 a.m. Eastern Time.  The conference will be held March 16-19, 2009 at The Boston Marriott C...
Jan 5, 2009
LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the 27th Annual J.P. Morgan Healthcare Conference, being held at the Westin St. Francis Hotel in San Francisco, California.  Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Monday...
Nov 24, 2008
LEXINGTON, MA -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the 20th Annual Piper Jaffray Health Care Conference, being held at The New York Palace in New York City. Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Tuesday, December 2, 2008 at...
Oct 28, 2008
LEXINGTON, MA -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the Oppenheimer 19th Annual Healthcare Conference, being held at the Waldorf-Astoria Hotel in New York City. Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Tuesday, November 4, 2008 at 8:20 a....
Oct 27, 2008
Washington, DC – Concert Pharmaceuticals, Inc. today announced findings from a preclinical study suggesting that C-20081, a novel, deuterium-containing oxazolidinone antibiotic, may be suitable for once-daily oral and intravenous dosing.  In the preclinical study, C-20081 had a 43% increase in plasma half-life co...
FirstPrevious
...
17
NextLast
= add release to Briefcase